Molecular Monitoring in Acute Myeloid Leukemia Patients Undergoing Matched Unrelated Donor – Hematopoietic Stem Cell Transplantation: Single Center Experience

Publié en ligne: 08 déc. 2020

Pages: 5 - 12

DOI: https://doi.org/10.2478/prilozi-2020-0040

Mots clés

minimal residual disease (MRD), molecular monitoring, matched unrelated donor (MUD) hematopoietic stem cell transplantation (HSCT), acute myeloid leukemia (AML), RUNX-RUNX1T1, CBFB-MYH11, CEBPA

© 2020 Irina Panovska-Stavridis et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.